Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
16 participants
INTERVENTIONAL
2025-06-21
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Fasted- Versus Fed-exercise on Metabolic Health in Physically Active Adults
NCT06949709
Time Efficient Exercise in Type 2 Diabetes
NCT02340260
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
NCT05123963
Effect of High-intensity Interval Training on Metabolic Fitness in Overweight Males.
NCT02798666
Optimization of Interval-training in Patients With Type 2 Diabetes
NCT02601482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sensors for measuring muscle oxygen (10 cm proximal to the mid-patella, and 2 cm lateral) will be placed on the rectus femoris muscle and 15 min resting metabolic rate was measured. After baseline measurements, participants warm-up for 3 minutes with fixed walking intensity (i.e., 5 km/h) followed by 40 minutes running. Immediately after the running, participants return to a seated position for 30 minutes post-exercise measurements (EPOC).
During the EPOC and resting metabolic rate (RMR) measurement participants will sit in a comfortable position and need to limit fidgeting, thus allowed only to watch TV or videos on their phone. Participants will be wheeled to the bathroom if needed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate-intensity continuous running (MICE: 60% V̇O2max)
Exercise
Moderate-intensity continuous running (MICE: 60% V̇O2max)
Participants run continuously for 40 minutes at moderate intensity (60-65% V̇O2max)
5-minute interval running (5MIN)
Exercise
5-minute interval running (5MIN)
Participants run for 40 minutes at average moderate intensity with 5-minutes slow and fast cycles where speed is increased and decreased by 20%.
2-minute interval running (2MIN)
Exercise
2-minute interval running (2MIN)
Participants run for 40 minutes at average moderate intensity with 2-minutes slow and fast cycles where speed is increased and decreased by 20%.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate-intensity continuous running (MICE: 60% V̇O2max)
Participants run continuously for 40 minutes at moderate intensity (60-65% V̇O2max)
5-minute interval running (5MIN)
Participants run for 40 minutes at average moderate intensity with 5-minutes slow and fast cycles where speed is increased and decreased by 20%.
2-minute interval running (2MIN)
Participants run for 40 minutes at average moderate intensity with 2-minutes slow and fast cycles where speed is increased and decreased by 20%.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5-27 kg/m2
* Aged between 20 to 45 years
* Regular exercise (3 times per week and longer than 3 months) with cardio exercise longer than 30 minutes at least once a week
* Weight stable for more than 3 months (no change in weight +/- 3%)
* Non-shift workers and sleep at least 6.5-9 hours for the past 3 months
* Non-smoker
Exclusion Criteria
* suffering from infectious contagious diseases,
* using medications that could affect metabolic responses (including anti-inflammatory medications)
* smoking
* heavy alcohol intake (more than 4 drinks on any day or more than 14 drinks a week).
* undergoing special diets (e.g., intermittent fasting and/or ketogenic diets)
20 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan Normal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yung-Chih Chen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan Normal University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202502HM010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.